Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK K HERSCHEL

Allopathic & Osteopathic Physicians Ophthalmology Cornea and External Diseases Specialist

NPI
1124083068
CMS profile
51146
Location
WINTER PARK, FL

General Payments · PY2018–2024

$6,012.66

  • Reported across 129 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$429.07

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $429.07 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GLAUKOS CORPORATION $142.19 6
Bausch & Lomb Americas Inc. $141.03 1
Tarsus Pharmaceuticals, Inc. $48.52 2
RxSight Inc $25.25 1
Harrow Eye, LLC $24.23 1
SUN PHARMACEUTICAL INDUSTRIES INC. $23.96 1
Dompe US, Inc. $23.89 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $372.63 22
PY2019 $2,204.95 32
PY2020 $2,016.17 25
PY2021 $320.19 14
PY2022 $199.13 6
PY2023 $470.52 17
PY2024 $429.07 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Bausch & Lomb Americas Inc. $141.03 07/12/2024 Food and Beverage Undisputed 01/23/2026 1140403086 CMS
Dompe US, Inc. $23.89 10/31/2024 Food and Beverage Undisputed 01/23/2026 1151410485 CMS
Glaukos Corporation $26.78 01/25/2024 Food and Beverage Undisputed 01/23/2026 1151994650 CMS
Glaukos Corporation $20.10 04/19/2024 Food and Beverage Undisputed 01/23/2026 1151994644 CMS
Glaukos Corporation $13.87 04/25/2024 Food and Beverage Undisputed 01/23/2026 1151994642 CMS
Glaukos Corporation $39.14 11/13/2024 Food and Beverage Undisputed 01/23/2026 1151989758 CMS
Glaukos Corporation $21.78 12/11/2024 Food and Beverage Undisputed 01/23/2026 1151994648 CMS
Glaukos Corporation $20.52 12/12/2024 Food and Beverage Undisputed 01/23/2026 1151994646 CMS
Harrow Eye, LLC $24.23 03/28/2024 Food and Beverage Undisputed 01/23/2026 1145604890 CMS
RxSight Inc $25.25 11/14/2024 Food and Beverage Undisputed 01/23/2026 1144218282 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $23.96 02/21/2024 Food and Beverage Undisputed 01/23/2026 1152178502 CMS
Tarsus Pharmaceuticals, Inc. $17.68 03/20/2024 Food and Beverage Undisputed 01/23/2026 1139102791 CMS
Tarsus Pharmaceuticals, Inc. $30.84 10/03/2024 Food and Beverage Undisputed 01/23/2026 1139102793 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.